Apcalis SX (tadalafil)
Apcalis SX is described in the source catalogue as an Ajanta-associated tadalafil oral jelly.
- Active ingredient
- tadalafil
- Formulation
- Oral jelly
- Company in catalogue
- Ajanta Pharma Ltd
Apcalis SX is described in the source catalogue as an Ajanta-associated tadalafil oral jelly. It belongs with tadalafil products, rather than with sildenafil jellies that may have similar packaging.
What distinguishes this product
The recorded presentation is a 20 mg jelly. A sachet, a swallowed tablet and a dissolving tablet are separate formulations: a familiar ingredient does not establish the same directions or absorption. The product image shows the oral-jelly presentation; it does not establish the contents or authenticity of a supplied pack.
Product record
- Record type
- Indian branded generic
- Treatment area in this directory
- Erectile dysfunction (ED)
- Active ingredient
- tadalafil
- Formulation in the cited record
- Oral jelly
- Source-listed strengths
- 20 mg
- Company in the cited record
- Ajanta Pharma Ltd (Company attributed by the source catalogue)
- Manufacturing information
- A specific manufacturing site is not established by the cited catalogue record. Consult the country-specific label and pack.
- Market evidence
- Global reference; exact market authorization not established by this catalogue import
- Storage reported by source
- Store below 30°C Check the supplied leaflet for the exact presentation.
- Catalogue reviewed
Catalogue attributes describe the named product as reported by the source. Listed strengths are identification details, not dosing instructions. Ingredient evidence and company identity are useful signals; local product authorization is a separate question.
Ingredient references
These references cover the active ingredients. They do not verify every named brand, pack or formulation listed on this page.
How the ingredients fit treatment
Tadalafil is a PDE5 inhibitor with a longer duration of action than sildenafil. Its documented ED regimens include daily and as-needed treatment, using different prescribed strengths. A catalogue strength alone does not identify which regimen is appropriate.
Ingredient guidance and safe use
Read the ingredient guidance alongside the leaflet for the actual product. A different brand, strength or dosage form may need different instructions.
Do not combine a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing. Tell the treating team which medicine you took and when.
Commonly reported effects of oral PDE5 medicines include headache, flushing, indigestion and nasal congestion; the pattern varies by ingredient and product. The cited ingredient information covers adverse effects and restrictions in more detail.
Interactions and urgent symptoms · Understanding formulations · Finding a local medicine record
Related product records
- Cialis — tadalafil
- Forzest — tadalafil
- Sildalis — sildenafil + tadalafil
- Super Vidalista — tadalafil + dapoxetine